# Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)

Study · id `cardio:ct-nct01291329` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01291329](<https://clinicaltrials.gov/study/NCT01291329>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01291329

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 160 participants.

## Technical summary

Registry record NCT01291329. Randomized; quadruple masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT01291329, source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01291329, source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)
- Primary completion: 2012-02 (actual) (ClinicalTrials.gov record NCT01291329, source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)
- Completion: 2012-07 (actual) (ClinicalTrials.gov record NCT01291329, source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01291329, source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01291329-2015-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI)
- Acronym: WJ-MSC-AMI
- Condition: ST-Elevation Myocardial Infarction
- Intervention (Genetic): intracoronary human umbilical WJ-MSC transfer
- Lead sponsor: Navy General Hospital, Beijing
- Lead sponsor class: OTHER
- Collaborator: Chinese PLA General Hospital
- Collaborator class: OTHER
- Collaborator: General Hospital of Chinese Armed Police Forces
- Collaborator class: OTHER
- Collaborator: First People's Hospital of Foshan
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Navy General Hospital, Beijing (`cardio:org-navy-general-hospital-beijing`)
- Registry lists this organization as a collaborator: Chinese PLA General Hospital (`cardio:org-chinese-pla-general-hospital`)
- Registry lists this organization as a collaborator: General Hospital of Chinese Armed Police Forces (`cardio:org-general-hospital-of-chinese-armed-police-forces`)
- Registry lists this organization as a collaborator: First People's Hospital of Foshan (`cardio:org-first-people-s-hospital-of-foshan`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial (`cardio:pubmed-26162993`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: cacc3c5edcd965a0a38f513b459ba44c356115edd7b088bea7adc6a420bcb4c1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
